Company intelligence / Profile preview

Zeteo Health

Pflugerville / Cedar Park / Austin area, Texas, United Stateszeteo.health ↗

Ownership: Private
Development stage: Preclinical

Overview

Zeteo Biomedical has developed patented drug/device combination platforms—primarily focused on nasal, ophthalmic and sublingual routes—that enable precision dosing of biologics and small molecules. Their technologies are used by pharma/biotech partners to accelerate development/commercialization of patient-centric therapies. The company recently secured new US/EU patents expanding its portfolio.

Therapeutic areas: GastroenterologyImmunologyNeurologyInfectious Diseases
Modalities: DeviceBiologicSmall moleculeVaccine
Industry: Therapeutic Medical Devices

Partnerships

BARDA Rapid Response Partnership Vehicle Consortium memberstrategic CMO/CDMO manufacturing partners for fill-finish/drug-device assembly services

Beyond the preview

Go deeper on Zeteo Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zeteo Health.

Explore the full profile